New rules have been approved by US FDA CBER for body fluid exposure, tattooing, body fluid exposure, and body-piercing. By similar logic we will extend this also to HIJAMA. We will not make any changes to our sexual history/practices or history of sexually transmitted disease treatment or clotting factor deferrals (except fibrinogen.)
- Effective immediately, we will accept donors AFTER THREE MONTHS from the following activities:
- HIJAMA (ritual blood-letting)
- Body piercing (e.g. piercing for ear-rings)
- Contact with blood of another individual through percutaneous inoculation such as a needle stick or through contact with a donor’s open wound or mucous membranes
- A TWELVE-MONTH DEFERRAL still applies after receiving a blood component or blood derivative except clotting factors (excluding fibrinogen concentrate.)
- Transfusion of clotting factors remains a permanent/indefinite deferral.
Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products, Guidance for Industry, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, April 2020